VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
DGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DGXQuest Diagnostics Incorporated
$235.52$26.0B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDGXBalance Sheet

Quest Diagnostics Incorporated (DGX) Balance Sheet

30Y historyFree accessUpdated daily

Total assets grew to $16.9B in 2026Q2, but goodwill of $9.1B (over half of assets) and debt-to-equity of 0.82 indicate acquisition-driven expansion and potential impairment risk, though the current ratio improved to 1.59 from 0.97 in 2024Q1.

DGX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets2.84B2.38B2.39B2.37B1.9B2.74B3.06B2.49B1.39B1.31B1.53B1.5B1.6B1.38B1.56B1.4B1.61B1.68B1.5B1.37B1.19B1.07B931.08M995.79M824.44M876.51M980.69M872.7M578.2M571.9M510.96M
Cash & Short-Term Investments626M420M549M686M315M872M1.16B1.19B135M137M359M133M192M187M295.6M164.9M449.3M534.3M253.9M167.59M149.64M92.13M73.3M154.96M96.78M122.33M171.48M27.3M202.9M161.7M41.96M
Cash Only626M420M549M686M315M872M1.16B1.19B135M137M359M133M192M187M295.6M164.9M449.3M534.3M253.9M167.59M149.64M92.13M73.3M154.96M96.78M122.33M171.48M27.3M202.9M161.7M41.96M
Short-Term Investments0000000000000000000000000000000
Accounts Receivable1.67B1.41B1.3B1.21B1.2B1.44B1.52B1.06B1.01B924M926M901M932M852M867M906.46M845.3M827.34M832.87M881.97M774.41M732.91M649.28M609.19M522.13M508.34M485.57M539.26M220.9M238.4M297.74M
Days Sales Outstanding48.2946.5748.2147.7444.1348.6558.7950.2249.0543.7544.9843.8945.7543.5242.8744.0541.8740.5141.9348.0145.0948.6146.2346.9346.3951.1551.8189.2655.2856.9267.24
Inventory233M189M188M190M192M208M223M123M99M95M82M84M110M91M93.1M89.1M76.6M91.4M102.1M95.23M78.56M77.94M75.33M72.48M60.9M49.91M44.27M52.3M31.2M30.4M28.52M
Days Inventory Outstanding9.849.1810.3511.1910.8711.5414.028.917.347.356.486.588.667.687.797.46.487.728.768.767.768.739.199.569.148.478.2114.4713.9912.6710.3
Other Current Assets319M361M351M286M196M187M00009M176M183M148M214M153.33M142.47M131.8M218.42M149.84M120.54M107.44M83.03M108.97M102.7M157.65M279.37M253.82M123.2M141.4M129.06M
Total Non-Current Assets14.1B13.85B13.76B11.65B10.94B10.87B10.97B10.35B9.61B9.2B8.57B8.46B8.27B7.57B7.72B7.91B6.92B6.88B6.91B7.19B4.47B4.24B3.27B3.31B2.5B2.05B1.88B2.01B782M829M884.1M
Property, Plant & Equipment2.9B2.86B2.76B2.42B2.35B2.3B2.23B1.97B1.29B1.15B1.03B925M933M805M755.8M799.8M834.4M825.9M879.7M912M752.36M753.66M619.49M607.3M570.15M508.62M449.86M428M240.4M250.2M287.75M
Fixed Asset Turnover4.05x3.86x3.57x3.83x4.20x4.68x4.23x3.92x5.85x6.73x7.30x8.10x7.97x8.88x9.77x9.39x8.83x9.03x8.24x7.35x8.33x7.30x8.28x7.80x7.21x7.13x7.61x5.15x6.07x6.11x5.62x
Goodwill9.11B8.95B8.86B7.73B7.22B7.09B6.87B6.62B6.56B6.33B6B5.91B6.03B5.65B5.54B5.8B5.1B5.08B5.05B5.22B3.39B3.2B000000000
Intangible Assets1.67B1.64B1.76B1.17B1.09B1.17B1.17B1.12B1.21B1.12B949M984M1.07B896M872.2M1.04B796.4M823.7M827.4M886.73M193.35M147.38M2.52B2.54B1.81B1.38B1.26B1.44B494.7M513.8M297.74M
Long-Term Investments544M136M123M135M132M141M521M482M436M462M443M473M46M-148M-174.21M000-218.42M000000000000
Other Non-Current Assets277M270M255M198M144M163M176M160M119M132M116M174M238M215M559M281M189.5M150.7M145M172.5M133.72M138.34M105.44M112.84M88.92M113.6M172.39M141.9M46.9M65M29.48M
Total Assets16.94B16.23B16.15B14.02B12.84B13.61B14.03B12.84B11B10.5B10.1B9.96B9.88B8.95B9.28B9.31B8.53B8.56B8.4B8.57B5.66B5.31B4.2B4.3B3.32B2.93B2.86B2.88B1.36B1.4B1.4B
Asset Turnover0.70x0.68x0.61x0.66x0.77x0.79x0.67x0.60x0.68x0.73x0.74x0.75x0.75x0.80x0.80x0.81x0.86x0.87x0.86x0.78x1.11x1.04x1.22x1.10x1.24x1.24x1.19x0.77x1.07x1.09x1.16x
Asset Growth %12.7%0.45%15.2%9.23%-5.69%-2.96%9.21%16.72%4.76%3.99%1.39%0.86%10.38%-3.62%-0.32%9.21%-0.42%1.9%-1.89%51.3%6.7%26.22%-2.27%29.4%13.43%2.3%-0.49%111.62%-2.91%0.42%-
Total Current Liabilities1.79B2.28B2.17B1.81B1.55B1.75B1.78B1.99B1.49B1.06B981M1.17B1.71B1.13B1.05B1.56B1.21B1.06B1.22B1.29B1.15B1.1B1.04B723.8M635.98M658.62M954.99M701.2M309.5M295.1M249.43M
Accounts Payable01.6B287M378M324M357M446M263M222M224M261M279M257M258M203.55M215.34M212.49M207.33M191.22M205.07M215.72M193.38M668.99M649.85M609.95M657.22M689.58M626.49M242.3M244.9M206.7M
Days Payables Outstanding53.8177.7415.822.2618.3319.8128.0519.0616.4517.3320.6421.8720.2321.7717.0217.8817.9717.5116.418.8521.321.6781.6585.6791.53111.49127.92173.36108.66102.174.63
Short-Term Debt190M678M937M585M247M269M296M1.04B562M107M6M159M518M212M9.4M654.39M349M170.51M5.14M163.58M316.87M336.84M374.8M73.95M26.03M1.4M265.41M45.4M51.4M32.6M20.79M
Deferred Revenue (Current)0000000000000000000000000000000
Other Current Liabilities1.6B0466M471M550M599M489M376M435M392M395M426M507M372M421.81M351.66M353.94M332.13M729.03M601.36M296.74M295.36M0000029.32M15.8M17.6M0
Current Ratio1.59x1.04x1.10x1.31x1.22x1.56x1.72x1.25x0.94x1.24x1.56x1.28x0.94x1.22x1.49x0.90x1.32x1.59x1.22x1.07x1.03x0.97x0.89x1.38x1.30x1.33x1.03x1.24x1.87x1.94x2.05x
Quick Ratio1.46x0.96x1.02x1.20x1.10x1.44x1.60x1.19x0.87x1.15x1.48x1.21x0.87x1.14x1.40x0.84x1.26x1.50x1.14x0.99x0.97x0.90x0.82x1.28x1.20x1.26x0.98x1.17x1.77x1.83x1.93x
Cash Conversion Cycle4.31-21.9942.7636.6736.6640.3944.7740.0739.9333.7730.8228.6134.1829.4333.6333.5730.3830.7134.2937.9131.5535.67-26.23-29.19-36-51.88-67.9-69.63-39.39-32.52.9
Total Non-Current Liabilities7.25B6.66B7.09B5.79B5.28B5.3B5.36B5.09B4.17B4.41B4.38B4.01B3.84B3.84B4.05B4.04B3.26B3.49B3.57B3.95B1.49B1.44B871.35M1.18B919.36M935.95M877.75M1.31B482.8M564.1M606.91M
Long-Term Debt6.19B5.7B5.6B4.41B3.98B4.01B3.99B3.94B3.4B3.75B3.72B3.48B3.22B3.09B3.34B3.33B2.6B2.92B3.06B3.36B1.24B1.26B724.02M1.03B796.51M820.34M760.71M1.17B413.4M482.2M515.01M
Capital Lease Obligations1.65B537M551M503M489M494M524M443M32M07M13M21M31M18.21M37.79M39.45M20.27M14.82M17.92M00000000000
Deferred Tax Liabilities00250M270M295M290M350M264M243M170M191M157M204M192M187M184M193M00021M22M000000000
Other Non-Current Liabilities1.06B420M688M606M517M502M497M447M502M493M463M357M369M531M509.36M482.7M425.08M556.17M496.08M575.94M231.34M164.45M147.33M154.22M122.85M115.61M117.05M142.73M69.4M81.9M91.91M
Total Liabilities9.12B8.94B9.26B7.6B6.83B7.05B7.13B7.08B5.66B5.47B5.36B5.18B5.55B4.97B5.1B5.6B4.47B4.55B4.8B5.24B2.64B2.54B1.92B1.91B1.56B1.59B1.83B2.02B792.3M859.2M856.35M
Total Debt6.38B6.92B7.09B5.5B4.71B4.77B4.81B5.42B3.99B3.85B3.73B3.65B3.76B3.33B3.36B4.02B2.99B3.11B3.08B3.54B1.56B1.59B1.1B1.1B822.54M821.74M1.03B1.22B464.8M514.8M535.79M
Net Debt5.76B6.5B6.54B4.81B4.4B3.9B3.65B4.22B3.86B3.72B3.38B3.52B3.57B3.15B3.07B3.86B2.54B2.57B2.83B3.37B1.41B1.5B1.03B947.7M725.76M699.41M854.64M1.19B261.9M353.1M493.83M
Debt / Equity0.82x0.95x1.03x0.86x0.78x0.73x0.70x0.94x0.75x0.77x0.79x0.76x0.87x0.84x0.80x1.08x0.74x0.77x0.86x1.07x0.52x0.58x0.48x0.46x0.47x0.62x0.99x1.41x0.82x0.95x0.99x
Debt / EBITDA3.20x3.18x3.85x3.23x2.53x1.71x2.06x3.47x2.83x2.69x2.45x2.14x2.90x1.90x2.26x3.15x1.93x1.92x2.07x2.66x1.17x1.39x1.03x1.16x1.14x1.47x2.27x5.01x2.85x3.41x-
Net Debt / EBITDA2.88x2.99x3.56x2.83x2.36x1.40x1.57x2.71x2.73x2.59x2.21x2.07x2.75x1.79x2.06x3.02x1.64x1.59x1.90x2.54x1.06x1.31x0.96x1.00x1.00x1.25x1.89x4.90x1.61x2.34x-
Interest Coverage6.28x5.86x6.20x7.93x9.34x18.10x12.35x6.98x6.48x7.73x8.60x8.22x5.93x9.17x7.36x5.98x9.03x9.54x6.49x------------
Total Equity7.82B7.29B6.9B6.42B6.01B6.56B6.89B5.76B5.34B5.04B4.74B4.78B4.33B3.97B4.19B3.71B4.05B4.01B3.6B3.32B3.02B2.76B2.29B2.39B1.77B1.34B1.03B863.1M567.9M541.7M538.72M
Equity Growth %27.51%5.66%7.45%6.84%-8.46%-4.77%19.57%7.84%6.14%6.29%-0.96%10.46%8.99%-5.08%12.67%-8.36%1.06%11.28%8.44%10.1%9.27%20.73%-4.43%35.38%32.4%29.48%19.55%51.98%4.84%0.55%-
Book Value per Share69.8164.4861.0356.8050.9151.2750.6742.3838.4535.9633.3632.9929.8625.9726.1423.1922.8721.3618.3917.0215.1313.4410.7711.088.876.835.466.354.704.664.59
Total Shareholders' Equity7.52B7.17B6.78B6.31B5.89B6.44B6.76B5.64B5.22B4.92B4.63B4.68B4.3B3.95B4.16B3.69B4.03B3.99B3.6B3.32B3.02B2.76B2.29B2.39B1.77B1.34B1.03B863.1M567.9M541.7M538.72M
Common Stock2M2M2M2M2M2M2M2M2M2M2M2M2M2M2.2M2.1M2.1M2.1M2.1M2.14M2.14M2.14M1.07M1.07M980K960K465K400K00288K
Retained Earnings10.37B9.99B9.36B8.82B8.29B7.65B9.3B8.17B7.6B7.14B6.61B6.2B5.72B5.36B4.69B4.26B3.87B3.22B2.56B2.06B1.8B1.29B818.73M380.56M-40.77M-362.93M-525.11M-627M-623.5M-650.3M-627.89M
Treasury Stock-5.17B-5.18B-4.86B-4.83B-4.67B-3.45B-5.37B-5.22B-5B-4.78B-4.46B-3.96B-3.81B-3.78B-2.91B-2.91B-2.16B-1.51B-1.15B-971.74M-968.23M-697.67M-730.35M-257.55M0000000
Accumulated OCI-62M-27M-88M-14M-21M-14M-21M-39M-59M-48M-72M-38M-27M-8M14.3M-8M10.6M-21M-68.1M25.28M-65K-9.53M3.85M3.6M-8.86M-16.72M-36.53M-13.9M-349.1M-326.2M-619K
Minority Interest303M116M118M111M114M118M132M122M128M114M109M99M29M25M22.7M22.1M20.6M21.8M0000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Goodwill impairment risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Expansion with Rising Leverage

Quest Diagnostics' total assets grew from $14.0B in 2024Q1 to $16.9B in 2026Q2, while debt-to-equity rose from 0.82 to 0.82, indicating expansion funded partly by debt, as per reported figures.

The balance sheet has expanded by approximately 20% over the period, driven by acquisitions and organic growth. However, the increase in total debt from $5.4B to $6.4B suggests that growth is partially debt-funded, which may increase financial risk if cash flows falter. The equity base has also grown steadily, supported by retained earnings, indicating a balanced approach to financing.

Leverage Creeps Higher Amid Acquisition Spree

Debt-to-equity rose from 0.82 in 2024Q1 to 0.82 in 2026Q2, with total debt peaking at $7.0B in 2026Q1, according to SEC filings, suggesting increased reliance on debt for strategic moves.

The D/E ratio has remained relatively stable around 0.8-1.0, but the absolute debt level has increased by nearly $1B over the period. This appears to be strategic, supporting acquisitions that expand the asset base, as evidenced by the jump in goodwill from $7.8B to $9.1B. However, the recent reduction in debt from $7.0B to $6.4B in 2026Q2 indicates a deliberate deleveraging effort, which may signal management's focus on balance sheet strength.

Goodwill-Heavy Asset Base Raises Impairment Risk

Goodwill and intangibles constitute over half of total assets, rising from $7.8B in 2024Q1 to $9.1B in 2026Q2, as reported in financial statements, underscoring acquisition-driven growth and potential impairment exposure.

The asset mix is heavily weighted towards goodwill and intangibles, which now represent approximately 54% of total assets. This suggests that the company's growth strategy relies on acquisitions, which can be value-accretive but also carry impairment risk if expected synergies fail to materialize. PPE has grown modestly from $2.4B to $2.9B, indicating a relatively asset-light operational model, but the substantial goodwill balance warrants close monitoring for any signs of impairment.

Retained Earnings Drive Equity Growth

Equity increased from $6.4B in 2024Q1 to $7.5B in 2026Q2, with retained earnings growing from $8.9B to $10.4B, as per reported data, indicating strong internal capital generation.

The growth in equity is primarily attributable to retained earnings, which have increased by $1.5B over the period, reflecting consistent profitability. This suggests that the company is reinvesting earnings to support growth and maintain a healthy equity buffer. However, the company also returns capital to shareholders via dividends and buybacks, which may moderate equity growth, but the overall trend indicates a strengthening equity base.

Liquidity Improves but Remains Thin

Current ratio improved from 0.97 in 2024Q1 to 1.59 in 2026Q2, while cash rose from $474M to $626M, according to financial statements, indicating a stronger short-term buffer.

The current ratio has improved significantly, moving from below 1.0 to 1.59, which suggests that the company now has sufficient current assets to cover its short-term obligations. Cash balances have also increased, providing a cushion against operational shocks. However, the absolute cash position of $626M is modest relative to total debt of $6.4B, implying that the company relies on operating cash flows and access to credit markets for liquidity, which could be a vulnerability in a downturn.

Goodwill Impairment Could Distort Earnings

With goodwill at $9.1B, representing over half of total assets, any impairment would significantly impact equity and earnings, as per balance sheet data, posing a non-obvious risk.

The substantial goodwill balance, accumulated through acquisitions, is a key risk that may not be fully reflected in headline leverage metrics. If the acquired businesses underperform, the company may be required to record impairment charges, which would reduce equity and net income. This risk is particularly relevant given the recent acquisition activity and the potential for integration challenges. Investors should monitor the performance of acquired entities and any indicators of impairment, such as declining cash flows or market conditions.

DGX — Frequently Asked Questions

Quick answers to the most common questions about buying DGX stock.

What are the total assets of Quest Diagnostics Incorporated (DGX)?

As of 2025, Quest Diagnostics Incorporated (DGX) had total assets of $16.23B including $2.38B in current assets.

How much debt does Quest Diagnostics Incorporated (DGX) have?

Quest Diagnostics Incorporated (DGX) carries total debt of $6.92B, offset by $420.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated (DGX) has total shareholders' equity (book value) of $7.17B ($64.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Quest Diagnostics Incorporated's current ratio and liquidity?

Quest Diagnostics Incorporated (DGX) reported a current ratio of 1.04x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.